{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:45:04Z","timestamp":1778748304008,"version":"3.51.4"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1097\/rct.0b013e31803e8c45","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T02:31:58Z","timestamp":1236220318000},"page":"868-875","source":"Crossref","is-referenced-by-count":74,"title":["Detection of Recurrent Ovarian Cancer at MRI"],"prefix":"10.1097","volume":"31","author":[{"given":"Chan Kyo","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung Kwan","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joon Young","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byoung-Gie","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heon","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-6-20210208","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1056\/NEJM199311183292108","article-title":"Cancer of the ovary.","volume":"329","author":"Cannistra","year":"1993","journal-title":"N Engl J Med"},{"key":"R3-6-20210208","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1200\/JCO.1991.9.7.1138","article-title":"Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience.","volume":"9","author":"Omura","year":"1991","journal-title":"J Clin Oncol"},{"key":"R4-6-20210208","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/jama.1995.03520300065039","article-title":"Ovarian cancer. Screening, treatment, and follow-up. NIH Consensus Development Panel on Ovarian Cancer.","volume":"273","year":"1995","journal-title":"JAMA"},{"key":"R5-6-20210208","first-page":"17","article-title":"Surgery for recurrent ovarian cancer.","volume":"27","author":"Rose","year":"2000","journal-title":"Semin Oncol"},{"key":"R6-6-20210208","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0002-9378(89)80054-7","article-title":"Serum CA 125 levels and surgical findings in patients undergoing secondary operations for epithelial ovarian cancer.","volume":"160","author":"Rubin","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"R7-6-20210208","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0090-8258(90)90076-W","article-title":"Does serum CA-125 level prior to second-look laparotomy for invasive ovarian adenocarcinoma predict size of residual disease?","volume":"38","author":"Patsner","year":"1990","journal-title":"Gynecol Oncol"},{"key":"R8-6-20210208","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1006\/gyno.1995.1121","article-title":"Monitoring cancer antigen 125 levels in induction chemotherapy for epithelial ovarian carcinoma and predicting outcome of second-look procedure.","volume":"57","author":"Folk","year":"1995","journal-title":"Gynecol Oncol"},{"key":"R9-6-20210208","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1148\/radiology.211.2.r99ma24519","article-title":"Treated ovarian cancer: comparison of MR imaging with serum CA-125 level and physical examination-a longitudinal study.","volume":"211","author":"Low","year":"1999","journal-title":"Radiology"},{"key":"R10-6-20210208","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s003300051000","article-title":"Value of (18F)-FDG positron emission tomography, computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma.","volume":"10","author":"Kubik-Huch","year":"2000","journal-title":"Eur Radiol"},{"key":"R11-6-20210208","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1148\/radiology.215.3.r00jn25761","article-title":"Staging of advanced ovarian cancer: comparison of imaging modalities-report from the Radiological Diagnostic Oncology Group.","volume":"215","author":"Tempany","year":"2000","journal-title":"Radiology"},{"key":"R12-6-20210208","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2214\/ajr.179.2.1790391","article-title":"Usefulness of FDG PET for assessment of early recurrent epithelial ovarian cancer.","volume":"179","author":"Cho","year":"2002","journal-title":"AJR Am J Roentgenol"},{"key":"R13-6-20210208","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1148\/radiol.2353040447","article-title":"Treated ovarian cancer: MR imaging, laparotomy reassessment, and serum CA-125 values compared with clinical outcome at 1 year.","volume":"235","author":"Low","year":"2005","journal-title":"Radiology"},{"key":"R14-6-20210208","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1148\/radiology.196.3.7644634","article-title":"Ovarian cancer recurrence: value of MR imaging.","volume":"196","author":"Forstner","year":"1995","journal-title":"Radiology"},{"key":"R15-6-20210208","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1148\/radiology.195.2.7724757","article-title":"Ovarian cancer: comparison of findings with perfluorocarbon-enhanced MR imaging, In-111-CYT-103 immunoscintigraphy, and CT.","volume":"195","author":"Low","year":"1995","journal-title":"Radiology"},{"key":"R16-6-20210208","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2214\/ajr.165.4.7676985","article-title":"Ovarian carcinoma: value of CT in predicting success of debulking surgery.","volume":"165","author":"Meyer","year":"1995","journal-title":"AJR Am J Roentgenol"},{"key":"R17-6-20210208","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/jmri.1880050521","article-title":"Imaging of ovarian cancer.","volume":"5","author":"Forstner","year":"1995","journal-title":"J Magn Reson Imaging"},{"key":"R18-6-20210208","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1148\/rg.233025105","article-title":"Multidetector CT of peritoneal carcinomatosis from ovarian cancer.","volume":"23","author":"Pannu","year":"2003","journal-title":"Radiographics"},{"key":"R19-6-20210208","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/PL00008466","article-title":"Positron emission tomography with 2-18Ffluoro-2-deoxy-D-glucose in oncology. Part II. The clinical value in detecting and staging primary tumours.","volume":"126","author":"Ak","year":"2000","journal-title":"J Cancer Res Clin Oncol"},{"key":"R20-6-20210208","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1200\/JCO.1999.17.3.894","article-title":"Additional value of whole_body posbody positron emission tomography with fluorine-18-2-fluoro-2-deoxy-d-glucose in recurrent colorectal cancer.","volume":"17","author":"Flamen","year":"1999","journal-title":"J Clin Oncol"},{"key":"R21-6-20210208","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1200\/JCO.2000.18.8.1689","article-title":"Positron emission tomography using (18)FFluorodeoxyglucose for monitoring primary chemotherapy in breast cancer.","volume":"18","author":"Schelling","year":"2000","journal-title":"J Clin Oncol"},{"key":"R22-6-20210208","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1006\/gyno.2001.6386","article-title":"2-Fluorine-18-fluoro-2-deoxy-d-glucose positron emission tomography in the diagnosis of recurrent ovarian cancer.","volume":"83","author":"Zimny","year":"2001","journal-title":"Gynecol Oncol"},{"key":"R23-6-20210208","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/gyno.2001.6246","article-title":"Positive emission tomography for evaluating a complete clinical response in patients with ovarian or peritoneal carcinoma: correlation with second-look laparotomy.","volume":"82","author":"Rose","year":"2001","journal-title":"Gynecol Oncol"},{"key":"R24-6-20210208","first-page":"3691","article-title":"Whole body positron emission tomography with 18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancer.","volume":"21","author":"Yen","year":"2001","journal-title":"Anticancer Res"},{"key":"R25-6-20210208","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1148\/radiol.2332031800","article-title":"Integrated FDG PET\/CT in patients with persistent ovarian cancer: correlation with histologic findings.","volume":"233","author":"Sironi","year":"2004","journal-title":"Radiology"},{"key":"R26-6-20210208","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ejrad.2005.04.006","article-title":"Evaluation of integrated whole-body PET\/CT in the detection of recurrent ovarian cancer.","volume":"56","author":"Hauth","year":"2005","journal-title":"Eur J Radiol"},{"key":"R27-6-20210208","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.ejso.2005.02.029","article-title":"(18)F-FDG PET\/CT in the evaluation of recurrent ovarian cancer: a prospective study on forty-one patients.","volume":"31","author":"Nanni","year":"2005","journal-title":"Eur J Surg Oncol"},{"key":"R28-6-20210208","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0090-8258(03)00336-6","article-title":"Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET\/CT.","volume":"90","author":"Bristow","year":"2003","journal-title":"Gynecol Oncol"},{"key":"R29-6-20210208","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0090-8258(92)90043-I","article-title":"Prognostic value of CA 125 in advanced ovarian cancer.","volume":"44","author":"Mogensen","year":"1992","journal-title":"Gynecol Oncol"},{"key":"R30-6-20210208","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1056\/NEJM199004123221512","article-title":"Second thoughts about second-look laparotomy in advanced ovarian cancer.","volume":"322","author":"Friedman","year":"1990","journal-title":"N Engl J Med"},{"key":"R31-6-20210208","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1006\/gyno.1994.1350","article-title":"Second-look laparotomy in ovarian cancer.","volume":"55","author":"Creasman","year":"1994","journal-title":"Gynecol Oncol"},{"key":"R32-6-20210208","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/1098-2388(200007\/08)19:1<54::AID-SSU9>3.0.CO;2-9","article-title":"Second-look and second surgery: second chance or second best?","volume":"19","author":"Sijmons","year":"2000","journal-title":"Semin Surg Oncol"},{"key":"R33-6-20210208","first-page":"630","article-title":"Computed tomography prior to second-look operation in advanced ovarian cancer.","volume":"62","author":"Goldhirsch","year":"1983","journal-title":"Obstet Gynecol"},{"key":"R34-6-20210208","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2214\/ajr.150.4.829","article-title":"CT prior to second-look operation in ovarian cancer.","volume":"150","author":"Silverman","year":"1988","journal-title":"AJR Am J Roentgenol"},{"key":"R35-6-20210208","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1006\/gyno.1993.1272","article-title":"Assessment of primary and metastatic ovarian cancer by positron emission tomography (PET) using 2-18Fdeoxyglucose (2-18FFDG).","volume":"51","author":"Hubner","year":"1993","journal-title":"Gynecol Oncol"},{"key":"R36-6-20210208","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00259-001-0750-9","article-title":"Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-d-glucose.","volume":"29","author":"Torizuka","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R37-6-20210208","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10147-005-0489-6","article-title":"Positron emission tomography with 18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancer.","volume":"10","author":"Takekuma","year":"2005","journal-title":"Int J Clin Oncol"},{"key":"R38-6-20210208","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2214\/ajr.176.6.1761449","article-title":"Clinical value of positron emission tomography with FDG for recurrent ovarian cancer.","volume":"176","author":"Nakamoto","year":"2001","journal-title":"AJR Am J Roentgenol"},{"key":"R39-6-20210208","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/jmri.1880030117","article-title":"Primary ovarian cancer: prospective comparison of contrast-enhanced CT and pre- and postcontrast, fat-suppressed MR imaging, with histologic correlation.","volume":"3","author":"Semelka","year":"1993","journal-title":"J Magn Reson Imaging"}],"container-title":["Journal of Computer Assisted Tomography"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004728-200711000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T01:38:27Z","timestamp":1618277907000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004728-200711000-00006"}},"subtitle":["Comparison With Integrated PET\/CT"],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/rct.0b013e31803e8c45","relation":{},"ISSN":["0363-8715"],"issn-type":[{"value":"0363-8715","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}